Vimarsana
Biggest News Aggregation in the World

Parsemus Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Parsemus Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Parsemus Foundation Today - Breaking & Trending Today

The 'IUD' for MEN that's 99% effective in blocking sperm could be available next year - Vimarsana News

The 'IUD' for MEN that's 99% effective in blocking sperm could be available next year

Researchers in Virginia who injected 23 men with the non-hormonal birth control - called ADAM - said sperm counts in participants' ejaculations dropped by 99 to 100 percent just a month after the procedure.

Trial Data Looks Promising for 'IUD For Men' - Vimarsana News

Trial Data Looks Promising for 'IUD For Men'

Contraline released promising data from the clinical trial it’s conducting to test the efficacy of Adam, its male birth control product. The nonhormonal gel seems to be doing a good job of blocking the flow of sperm to the vas deferens, and no serious adverse events have been reported.

Low-dose aspirin associated with anemia in older adults, study says - Vimarsana News

Low-dose aspirin associated with anemia in older adults, study says

Using low-dose aspirin was associated with a 20% increased incidence of anemia and decline in ferritin, or blood iron levels, in otherwise healthy older adults, according to a new analysis of an old study.

Source: upi.com
Common diabetes drug prevents the development of long COVID, study finds - Vimarsana News

Common diabetes drug prevents the development of long COVID, study finds

In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.

Treating COVID with Metformin Reduces Long COVID Rates - Vimarsana News

Treating COVID with Metformin Reduces Long COVID Rates

/PRNewswire/ -- A new study published in The Lancet Infectious Diseases supported by the Parsemus Foundation found a 41% reduction in Long COVID rates among...